Seropositivity for Human T-cell Lymphotropic Virus (HTLV) in Donors at the Eye Bank of I.R. Iran

Purpose: To determine the prevalence of Human T-cell Lymphotropic Virus (HTLV) in corneal donors at the Eye Bank of I.R. Iran from 2005 to 2007. Methods: Serologic tests for HTLV-1,2 were performed in all donors at the Eye Bank from August 2005 to July 2007. Hospital and medicolegal reports of HTLV-reactive cases as well as their geographic origin were reviewed. Results: Overall, 5533 donors including 4467 (80.7%) male subjects aged from 2 to 84 years were evaluated. Thirty seven (0.67%) cases with mean age of 45.8±17 (range 7-84) years were seropositive for HTLV-1,2 of whom 26 (70.3%) were male. The most common causes of death in HTLV-reactive cases were car accidents (37.8%) followed by cardiovascular diseases (24.3%), falls (10.8%) and drug intoxication (10.8%). No evidence of neurologic or hematologic disorders was found on reviewing the hospital and medicolegal reports of HTLV-reactive cases. Conclusion: This is the first report on HTLV-reactivity in corneal donors in Iran revealing a prevalence of 1 per 150 cases.

[1]  J. H. Strauss,et al.  CHAPTER 6 – Viruses Whose Life Cycle Uses Reverse Transcriptase , 2008 .

[2]  A. Turner,et al.  Lack of vision, loss of sight: consequences of mandatory HTLV screening in corneal transplantation , 2007, Transplant infectious disease : an official journal of the Transplantation Society.

[3]  M. Magoni,et al.  Human T-cell lymphotropic virus type I (HTLV-I) confirmed by PCR-Southern blot and sequencing analysis in a woman with tropical spastic paraparesis , 2006, Neurological Sciences.

[4]  J. Casseb,et al.  Clinical and epidemiological aspects of HTLV-II infection in São Paulo, Brazil: presence of tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM) simile diagnosis in HIV-1-co-infected subjects. , 2006, Revista do Instituto de Medicina Tropical de Sao Paulo.

[5]  H. Salomón,et al.  A possible case of myelopathy/tropical spastic paraparesis in an Argentinian woman with human T lymphocyte virus type II. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Houshmand,et al.  Prevalence of Human T-Lymphotropic Virus Type 1 among Blood Donors from Mashhad, Iran , 2003, Journal of Clinical Microbiology.

[7]  B. Shames,et al.  Human T‐Cell Lymphotrophic Virus Infection in Organ Donors: A Need to Reassess Policy? , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  A. Heredia,et al.  Development of a multiplex PCR assay for the simultaneous detection and discrimination of HIV-1, HIV-2, HTLV-I and HTLV-II. , 1996, Clinical and diagnostic virology.

[9]  B. Safai,et al.  Prevalence of HTLV type I infection in Iran: a serological and genetic study. , 1996, AIDS research and human retroviruses.

[10]  L. Resnick,et al.  The role of HTLV in HIV‐1 neurologic disease , 1991, Neurology.

[11]  I. Maruyama,et al.  Ocular manifestations in patients infected with human T-lymphotropic virus type I. , 1989, Japanese journal of ophthalmology.